Lv42
468 积分 2024-10-29 加入
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
19天前
已完结
Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy
24天前
已完结
Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia
26天前
已完结
Liver involvement in ANCA-associated vasculitis
1个月前
已完结
Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer
1个月前
已完结
Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
1个月前
已完结
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
4个月前
已完结
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
4个月前
已完结
Alternative splicing of Scn9a exon 5: mechanistic insights and therapeutic potential in pain disorders
5个月前
已关闭
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
5个月前
已完结